Mahindra Manulife Manufacturing Fund vs SBI Healthcare Opportunities Fund
Direct Plan, Growth option · Data as on 30-10-2026
Mahindra Manulife Manufacturing Fund is a Thematic fund and SBI Healthcare Opportunities Fund is a Thematic fund. In the year to 30-10-2026, Mahindra Manulife Manufacturing Fund (Direct) returned 1.4% and SBI Healthcare Opportunities Fund (Direct) returned 17.1%. Mahindra Manulife Manufacturing Fund charges 1.18% a year and SBI Healthcare Opportunities Fund 1.01% (Direct plans). Their portfolios overlap 13.3%: they hold 5 of the same securities.
Mahindra Manulife Manufacturing Fund
Thematic
- 1 year return
- 1.4%
- Expense ratio
- 1.18%
- NAV
- ₹10.39
SBI Healthcare Opportunities Fund
Thematic
- 1 year return
- 17.1%
- Expense ratio
- 1.01%
- NAV
- ₹588.16
Which is better, Mahindra Manulife Manufacturing or SBI Healthcare Opportunities? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- SBI Healthcare Opportunities returned more over 1 year: 17.1% against 1.4%.
- SBI Healthcare Opportunities costs less: 1.01% a year against 1.18% (Direct plans).
- SBI Healthcare Opportunities fell less in its worst fall since 26-06-2024: −13.5% against −23.2%.
- Mahindra Manulife Manufacturing holds more in large companies: 42.5% of the fund in large caps against 32.3%.
- SBI Healthcare Opportunities is the larger fund: ₹5,870 Cr against ₹648 Cr.
- Their portfolios overlap 13.3%: 5 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Mahindra Manulife Manufacturing Fund | SBI Healthcare Opportunities Fund |
|---|---|---|
| Fund house | Mahindra Manulife Mutual Fund | SBI Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹648 Cr (30-09-2026) | ₹5,870 Cr (30-09-2026) |
| NAV | ₹10.39 (Direct) | ₹588.16 (Direct) |
| Expense ratio (Direct) | 1.18% | 1.01% |
| Expense ratio (Regular) | 2.59% | 1.99% |
| Riskometer | Very High | Not available |
| Benchmark | Nifty India Manufacturing TRI | Not available |
| Launch date | 24-06-2024 | Not available |
| Minimum investment | ₹1,000 | Not available |
| Lock in | None | Not available |
| Fund managers | Renjith Sivaram, Navin Matta | Not available |
| Exit load | Exit load of 0.5%, if redeemed within 3 months. | Not available |
Mahindra Manulife Manufacturing vs SBI Healthcare Opportunities: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Mahindra Manulife Manufacturing Fund (Direct) | −4.11% | −3.97% | −0.05% | +1.36% | -- | -- | -- |
| SBI Healthcare Opportunities Fund (Direct) | +0.31% | −0.59% | +16.00% | +17.12% | +24.60% | +19.22% | +14.72% |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | +11.62% | +13.76% |
Category average: the average of the 235 Thematic funds, same plan type.
Mahindra Manulife Manufacturing vs SBI Healthcare Opportunities: Year-wise Returns
| Year | Mahindra Manulife ManufacturingMahindra Manulife Manufacturing | SBI Healthcare OpportunitiesSBI Healthcare Opportunities |
|---|---|---|
| 2026to date | +1.56% | +21.31% |
| 2025 | +7.64% | −2.50% |
| 2024 | -- | +43.75% |
| 2023 | -- | +39.72% |
| 2022 | -- | −5.01% |
| 2021 | -- | +21.48% |
Mahindra Manulife Manufacturing vs SBI Healthcare Opportunities: Rolling Returns
Every holding period of both funds, against Nifty India Manufacturing TRI, the benchmark of Mahindra Manulife Manufacturing Fund
Rolling returns
Every 1-year holding period, 332 of them, one for each trading day from 26-06-2025 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
Mahindra Manulife Manufacturing Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
Nifty India Manufacturing TRI
to
Aug 2025Oct 2024
to
Oct 2025Jan 2025
to
Jan 2026Apr 2025
to
Apr 2026Jul 2025
to
Jul 2026Sept 2025
to
Sept 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mahindra Manulife Manufacturing | 22.3 | 14.8 | 34.0 | 15.7 | 10.5 | 2.7 | 0.0 | 6.7% | 6.9% | −6.0% | 23.4% | 18% |
| SBI Healthcare Opportunities | 10.1 | 20.5 | 19.3 | 19.3 | 14.3 | 16.1 | 0.3 | 10.1% | 10.0% | −3.3% | 25.3% | 54% |
| Nifty India Manufacturing TRI | 20.5 | 11.4 | 15.7 | 29.5 | 14.2 | 6.6 | 2.1 | 9.1% | 10.4% | −6.6% | 29.7% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is Nifty India Manufacturing TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 26-06-2024. Past returns do not promise future returns.
Mahindra Manulife Manufacturing vs SBI Healthcare Opportunities: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 26-06-2024 to 30-10-2026: 29 instalments, ₹2,90,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| Mahindra Manulife ManufacturingMahindra Manulife Manufacturing Fund (Direct) | ₹2,90,000 | ₹3,03,329 | ₹13,329 | 3.7% |
| SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct) | ₹2,90,000 | ₹3,50,552 | ₹60,552 | 16.0% |
Mahindra Manulife ManufacturingMahindra Manulife Manufacturing Fund (Direct)
SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
Mahindra Manulife Manufacturing vs SBI Healthcare Opportunities: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Mahindra Manulife Manufacturing Fund (Direct) | SBI Healthcare Opportunities Fund (Direct) |
|---|---|---|
| Return (CAGR) | +1.36% | +17.12% |
| Standard deviation | 14.93% | 13.36% |
| Sharpe ratio | -0.26 | 0.89 |
| Sortino ratio | -0.35 | 1.33 |
| Maximum drawdown | −11.0% (31-03-2026) | −10.3% (23-10-2026) |
| Beta | 0.90 | 0.93 |
| Alpha | +2.33% | +5.25% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Mahindra Manulife Manufacturing Fund (Direct) | SBI Healthcare Opportunities Fund (Direct) |
|---|---|---|
| Return (CAGR) | +1.54% | +17.93% |
| Standard deviation | 14.91% | 15.96% |
| Sharpe ratio | -0.28 | 0.74 |
| Sortino ratio | -0.38 | 1.05 |
| Maximum drawdown | −23.2% (03-03-2025) | −30.5% (23-03-2020) |
| Beta | 0.89 | 0.91 |
| Alpha | −0.85% | +3.97% |
From daily NAVs, 26-06-2024 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Mahindra Manulife Manufacturing Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
Nifty India Manufacturing TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Mahindra Manulife Manufacturing Fund (Direct) | −23.2% | 27-09-2024 | 03-03-2025 | 06-05-2026 | 14 months | −8.3% |
| SBI Healthcare Opportunities Fund (Direct) | −13.5% | 07-01-2025 | 28-02-2025 | 17-07-2025 | 5 months | −3.8% |
| Nifty India Manufacturing TRI | −23.0% | 27-09-2024 | 07-04-2025 | 05-01-2026 | 9 months | −10.5% |
From daily values since 26-06-2024, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Mahindra Manulife Manufacturing Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
Nifty India Manufacturing TRI
Against Nifty India Manufacturing TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| Mahindra Manulife Manufacturing Fund (Direct) | 95% | 95% | 5.82% |
| SBI Healthcare Opportunities Fund (Direct) | 100% | 34% | 13.74% |
From month-end values since 26-06-2024. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
Mahindra Manulife Manufacturing vs SBI Healthcare Opportunities: Portfolio Overlap
From each fund's latest monthly portfolio: Mahindra Manulife Manufacturing Fund, September 2026; SBI Healthcare Opportunities Fund, September 2026
Holdings in common
- Overlap
- 13.3%
- Held by both
- 5
- Only in Mahindra Manulife Manufacturing
- 45
- Only in SBI Healthcare Opportunities
- 31
| Security | % of Mahindra Manulife Manufacturing | % of SBI Healthcare Opportunities |
|---|---|---|
| Divi's Laboratories Limited | 5.42% | 7.91% |
| Sun Pharmaceutical Industries Limited | 3.92% | 11.14% |
| Anthem Biosciences Limited | 2.05% | 2.75% |
| Sai Life Sciences Limited | 0.94% | 2.60% |
| Cipla Limited | 0.93% | 4.40% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 13.3% means 13.3% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Mahindra Manulife Manufacturing Fund
| Security | % of fund |
|---|---|
| Mahindra & Mahindra Limited | 4.42% |
| SPR Auto Technologies Ltd | 4.21% |
| Reliance Industries Limited | 3.68% |
| Tata Steel Limited | 3.60% |
| Hindalco Industries Limited | 3.44% |
Largest holdings only in SBI Healthcare Opportunities Fund
| Security | % of fund |
|---|---|
| Acutaas Chemicals Ltd. | 5.03% |
| Apollo Hospitals Enterprise Ltd. | 4.45% |
| Torrent Pharmaceuticals Ltd. | 4.42% |
| Laurus Labs Ltd. | 4.05% |
| Max Healthcare Institute Ltd. | 3.80% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Mahindra Manulife Manufacturing | SBI Healthcare Opportunities |
|---|---|---|
| Equity | 94.8% | 95.5% |
| Debt | 0.0% | 0.1% |
| Cash and others | 5.3% | 4.4% |
Market cap of stocks
| Market cap | Mahindra Manulife Manufacturing | SBI Healthcare Opportunities |
|---|---|---|
| Large Cap | 42.5% | 32.3% |
| Mid Cap | 13.0% | 25.7% |
| Small Cap | 39.3% | 35.4% |
| Not on AMFI's list | 0.0% | 2.2% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Mahindra Manulife Manufacturing | SBI Healthcare Opportunities |
|---|---|---|
| Pharmaceuticals & Biotechnology | 13.3% | 63.1% |
| Healthcare Services | 0.0% | 25.6% |
| Auto Components | 15.8% | 0.0% |
| Industrial Products | 11.9% | 0.0% |
| Automobiles | 8.6% | 0.0% |
| Aerospace & Defense | 6.2% | 0.0% |
| Industrial Manufacturing | 5.8% | 0.0% |
| Chemicals & Petrochemicals | 3.1% | 5.0% |
| Healthcare Equipment & Supplies | 0.0% | 1.8% |
The six largest sectors of each fund's stocks, % of the fund.
Mahindra Manulife Manufacturing vs SBI Healthcare Opportunities: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Mahindra Manulife Manufacturing Fund | SBI Healthcare Opportunities Fund |
|---|---|---|
| Total expense ratio (Direct) | 1.18% | 1.01% |
| Base expense ratio (Direct) | 0.80% | 0.74% |
| Total expense ratio (Regular) | 2.59% | 1.99% |
| Base expense ratio (Regular) | 2.06% | 1.58% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Mahindra Manulife Manufacturing with
Mahindra Manulife Manufacturing Fund vs SBI Healthcare Opportunities Fund: Frequently Asked Questions
What is the difference between Mahindra Manulife Manufacturing Fund and SBI Healthcare Opportunities Fund?
Mahindra Manulife Manufacturing Fund is a Thematic fund, SBI Healthcare Opportunities Fund is a Thematic fund, run by Mahindra Manulife Mutual Fund and SBI Mutual Fund. Their portfolios overlap 13.3%. Mahindra Manulife Manufacturing Fund charges 1.18% a year and SBI Healthcare Opportunities Fund 1.01%.
Which has given higher returns, Mahindra Manulife Manufacturing Fund or SBI Healthcare Opportunities Fund?
Over 1 year: Mahindra Manulife Manufacturing Fund +1.36%, SBI Healthcare Opportunities Fund +17.12%. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, Mahindra Manulife Manufacturing Fund or SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund charges less: 1.01% a year against 1.18%. These are the Direct plans' total expense ratios reported to AMFI.
How much do Mahindra Manulife Manufacturing Fund and SBI Healthcare Opportunities Fund overlap?
13.3%. They hold 5 of the same securities, the largest shared ones being DIVISLAB, SUNPHARMA, ANTHEM. From each fund's latest monthly portfolio.
Can I invest in both Mahindra Manulife Manufacturing Fund and SBI Healthcare Opportunities Fund?
Yes. 13.3% of each fund's money sits in the same holdings, so some of the two investments would move together.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.